StockData
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS) stock

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30
$0.23+0.01 (+6.53%)

Close on Nov 17, 2026Market cap $16.64MP/E –Yield –

Acumen Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Acumen Pharmaceuticals's total debt was $20.40M at Sep 30, 2026. For fiscal 2025 it was $8.77M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.77M–
FY2024Dec 31, 2024$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$20.40M+467.1%
Q2 FY2026Jun 30, 2026$19.67M–
Q1 FY2026Mar 31, 2026$14.12M–
Q4 FY2025Dec 31, 2025$8.77M–
Q3 FY2025Sep 30, 2025$3.60M–
Q4 FY2024Dec 31, 2024$0–

More Acumen Pharmaceuticals figures

See a number that looks wrong?